retatrutide vs ozempic Ozempic: Clinical Trial Comparisons Retatrutide vs Ozempic and Mounjaro:

The steep weight loss and significant cardiovascular and metabolic benefits associated with drugs like semaglutide and tirzepatide underlie their rapid rise in popularity

The global GLP-1 market was valued at $52.82 billion in 2025 and is projected to reach $133.92 billion by 2034, growing at 10.9 percent annually

Liraglutide weight loss clinical trials Semaglutide is another GLP-1 product developed by Novo Nordisk with a better weight loss effect than liraglutide

These include Ozempic (semaglutide) and Mounjaro (tirzepatide), which have the follow costs without insurance: Bottom line As the first oral GLP-1 approved for weight loss, the Wegovy pill offers a needle-free alternative that is often more affordable than injectable options